Hyperemesis gravidarum: a review of recent literature

V London, S Grube, DM Sherer, O Abulafia - Pharmacology, 2017 - karger.com
Abstract Background: In the United States, hyperemesis gravidarum is the most common
cause of hospitalization during the first half of pregnancy and is second only to preterm labor …

Hyperemesis gravidarum

K Austin, K Wilson, S Saha - Nutrition in Clinical Practice, 2019 - Wiley Online Library
Nausea and vomiting of pregnancy affect the majority of pregnancies, while the most severe
version, hyperemesis gravidarum (HG), affects a much smaller subset of women. Despite the …

Women's perspectives on the management and consequences of hyperemesis gravidarum–a descriptive interview study

GC Havnen, MBT Truong, MLH Do… - … journal of primary …, 2019 - Taylor & Francis
Objective: Hyperemesis gravidarum (HG) affects 0.3–3% of pregnant women and is a
leading cause of hospitalization in early pregnancy. The aim of the study was to investigate …

Mirtazapine exposure in pregnancy and fetal safety: A nationwide cohort study

A Ostenfeld, TS Petersen, LH Pedersen… - Acta Psychiatrica …, 2022 - Wiley Online Library
Objective To investigate the association between mirtazapine exposure in pregnancy and
risk of specific adverse pregnancy outcomes. Methods A register‐based nationwide cohort …

Pharmacologic treatment of perinatal depression

MC Kimmel, E Cox, C Schiller, E Gettes… - Obstetrics and …, 2018 - obgyn.theclinics.com
Perinatal depression, defined as depressive symptoms occurring either during pregnancy
(antenatal depression [AND]) or postpartum (postpartum depression [PPD]) 1, 2 is …

Validating the effect of Ondansetron and Mirtazapine in Treating hyperemesis gravidarum (VOMIT): protocol for a randomised placebo-controlled trial

A Ostenfeld, TS Petersen, TB Futtrup, JT Andersen… - BMJ open, 2020 - bmjopen.bmj.com
Introduction Current pharmacological treatment options for hyperemesis gravidarum have
been introduced based on scarce evidence and are often not sufficiently effective. Several …

Use of mirtazapine and olanzapine in the treatment of refractory hyperemesis gravidarum: A case report and systematic review

MAK Galletta, VLC Tess, IM Pasotti… - Case Reports in …, 2022 - Wiley Online Library
Hyperemesis gravidarum (HG) is a rare condition (1.1%) characterized by excessive
vomiting, malnutrition, dehydration, and laboratorial alterations. Herein, we describe the …

Safety and effectiveness of Japanese herbal Kampo medicines for treatment of hyperemesis gravidarum

N Michihata, D Shigemi, Y Sasabuchi… - … of Gynecology & …, 2019 - Wiley Online Library
Abstract Objectives To investigate whether Japanese Kampo medicines, including Sho‐
hange‐kabukuryou‐to, Touki‐syakuyaku‐san, and Hange‐kouboku‐to, are safe for fetuses …

[HTML][HTML] When is parenteral nutrition indicated?

MM Berger, C Pichard - Journal of intensive medicine, 2022 - Elsevier
The indications and contraindications of parenteral nutrition (PN) are discussed in view of
recent clinical findings. For decades, PN has been restricted to patients unable to tolerate …

Thyroid‐stimulating hormone and free thyroxine fail to predict the severity and clinical course of hyperemesis gravidarum: A prospective cohort study

K Nijsten, MH Koot, JAM van der Post… - Acta Obstetricia et …, 2021 - Wiley Online Library
Introduction Little is known about the pathophysiology of hyperemesis gravidarum (HG).
Proposed underlying causes are multifactorial and thyroid function is hypothesized to be …